Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Fossil Group
FOSL
$330M
| $2.31M | ﹤0.01% |
1,562,064
+51,979
| +3% | +$65.5K |
|
2027
Invesco S&P 500 Quality ETF
SPHQ
$20.1B
| $2.31M | ﹤0.01% |
+32,400
| New | +$2.19M |
|
2028
Lennar Class B
LEN.B
$20.1B
| $2.3M | ﹤0.01% |
21,852
-23,500
| -52% | -$2.43M |
|
2029
Mayville Engineering Co
MEC
$597M
| $2.3M | ﹤0.01% |
144,000
+58,100
| +68% | +$830K |
|
2030
Ceragon Networks
CRNT
$198M
| $2.3M | ﹤0.01% |
933,435
-356,200
| -28% | -$813K |
|
2031
Third Coast Bancshares
TCBX
$758M
| $2.28M | ﹤0.01% |
69,739
-30,161
| -30% | -$920K |
|
2032
N-able
NABL
$695M
| $2.27M | ﹤0.01% |
280,300
-175,100
| -38% | -$1.31M |
|
2033
State Street SPDR S&P Regional Banking ETF
KRE
$4.67B
| $2.27M | ﹤0.01% |
+38,200
| New | +$2.13M |
|
|
ITRG
2034
Integra Resources
ITRG
$550M
| $2.26M | ﹤0.01% |
1,506,180
+864,600
| +135% | +$1.39M |
|
2035
COPT Defense Properties
CDP
$4.23B
| $2.26M | ﹤0.01% |
81,800
-294,800
| -78% | -$7.98M |
|
2036
American Electric Power
AEP
$67.9B
| $2.25M | ﹤0.01% |
21,669
-39,331
| -64% | -$4.09M |
|
|
AVDL
2037
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.24M | ﹤0.01% |
253,600
-87,400
| -26% | -$768K |
|
2038
Liberty Energy
LBRT
$3.52B
| $2.23M | ﹤0.01% |
194,400
-27,500
| -12% | -$333K |
|
|
NUVL
2039
DELISTED
Nuvalent
NUVL
| $2.23M | ﹤0.01% |
29,200
+500
| +2% | +$36.6K |
|
2040
Core & Main
CNM
$8.62B
| $2.23M | ﹤0.01% |
36,900
-281,700
| -88% | -$15.1M |
|
2041
Vanguard Total World Stock ETF
VT
$81.9B
| $2.22M | ﹤0.01% |
+17,300
| New | +$2.07M |
|
2042
Clearfield
CLFD
$395M
| $2.22M | ﹤0.01% |
51,200
-4,800
| -9% | -$165K |
|
2043
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.75B
| $2.22M | ﹤0.01% |
+35,500
| New | +$2.14M |
|
|
AXIA
2044
DELISTED
AXIA Energia
AXIA
| $2.22M | ﹤0.01% |
377,336
+255,851
| +211% | +$1.49M |
|
2045
YieldMax COIN Option Income Strategy ETF
CONY
$334M
| $2.22M | ﹤0.01% |
+24,290
| New | +$1.95M |
|
|
BCYC
2046
Bicycle Therapeutics
BCYC
$284M
| $2.21M | ﹤0.01% |
318,400
+16,900
| +6% | +$135K |
|
2047
Build-A-Bear
BBW
$474M
| $2.21M | ﹤0.01% |
42,877
-8,000
| -16% | -$339K |
|
2048
Turkcell
TKC
$4.74B
| $2.21M | ﹤0.01% |
+364,900
| New | +$2.22M |
|
2049
Vestis
VSTS
$1.87B
| $2.21M | ﹤0.01% |
385,000
+7,000
| +2% | +$49.1K |
|
2050
Global X MLP ETF
MLPA
$2.28B
| $2.2M | ﹤0.01% |
43,900
+22,900
| +109% | +$1.14M |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.